Education
About Us
Working with TipRanks
Follow Us
BioView Ltd. (IL:BIOV)
:BIOV
Total Valuation
Bio View has a market cap or net worth of 26.78M. The enterprise value is 4.30B.
Market Cap26.78M
Enterprise Value4.30B
Share Statistics
Bio View has 136,653,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding136,653,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio View’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -12.48%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-12.48%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee777.42K
Profits Per Employee-86.58K
Employee Count33
Asset Turnover0.76
Inventory Turnover1.21
Valuation Ratios
The current PE Ratio of Bio View is -12.64. Bio View’s PEG ratio is -126.89.
PE Ratio-12.64
PS Ratio0.00
PB Ratio181.10
Price to Fair Value1.73
Price to FCF10.02K
Price to Operating Cash Flow5.29K
PEG Ratio-126.89
Income Statement
In the last 12 months, Bio View had revenue of 25.66M and earned -3.15M in profits. Earnings per share was -0.02.
Revenue25.66M
Gross Profit15.56M
Operating Income-2.88M
Pretax Income-2.86M
Net Income-3.15M
EBITDA-943.00K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.25M and capital expenditures -60.00K, giving a free cash flow of -1.31M billion.
Operating Cash Flow-1.25M
Free Cash Flow-1.31M
Free Cash Flow per Share>-0.01
Dividends & Yields
Bio View pays an annual dividend of 200, resulting in a dividend yield of ―
Dividend Per Share200
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change-25.19%
50-Day Moving Average24.33
200-Day Moving Average27.77
Relative Strength Index (RSI)32.54
Average Volume (3m)86.17K
Important Dates
Bio View upcoming earnings date is Nov 18, 2021, TBA (Confirmed).
Last Earnings DateAug 19, 2021
Next Earnings DateNov 18, 2021
Ex-Dividend DateMar 22, 2017
Financial Position
Bio View as a current ratio of 2.51, with Debt / Equity ratio of 14.35%
Current Ratio2.51
Quick Ratio1.65
Debt to Market Cap0.00
Net Debt to EBITDA6.61
Interest Coverage Ratio-13.38
Taxes
In the past 12 months, Bio View has paid 291.00K in taxes.
Income Tax291.00K
Effective Tax Rate-0.10
Enterprise Valuation
Bio View EV to EBITDA ratio is -35.57, with an EV/FCF ratio of -10.68.
EV to Sales1.31
EV to EBITDA-35.57
EV to Free Cash Flow-10.68
EV to Operating Cash Flow-10.80
Balance Sheet
Bio View has 16.80M in cash and marketable securities with 2.80M in debt, giving a net cash position of -13.99M billion.
Cash & Marketable Securities16.80M
Total Debt2.80M
Net Cash-13.99M
Net Cash Per Share-0.10
Tangible Book Value Per Share0.16
Margins
Gross margin is 57.20%, with operating margin of -11.21%, and net profit margin of -12.27%.
Gross Margin57.20%
Operating Margin-11.21%
Pretax Margin-11.14%
Net Profit Margin-12.27%
EBITDA Margin-3.68%
EBIT Margin-10.30%
Analyst Forecast
The average price target for Bio View is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―